(Q34318803)

1 August 2017

1 reference

title

Topics in migraine management: a survey of headache specialists highlights some controversies (English)

1 reference

1 August 2017

1 reference

1 reference

2

Lipton RB

1 reference

1 August 2017

Evans RW

1

1 reference

1 August 2017

publication date

1 February 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

1-21

1 reference

Stroke in migraine as a consequence of propranolol

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Migraine and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

The neuroleptic malignant and serotonin syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

A persistent migraine aura

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Expert opinion: assessing cardiac risk prior to use of triptans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

An occurrence of complicated migraine during propranolol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

The serotonin syndrome and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Ischemic stroke risk with oral contraceptives: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

The scientific basis of medication choice in symptomatic migraine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Monitoring of acute migraine attacks: placebo response and safety data

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Headache after frequent use of serotonin agonists zolmitriptan and naratriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Disability assessment as a basis for stratified care

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Medical consultation for migraine: results from the American Migraine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Serotonin syndrome complicating migraine pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Atrial fibrillation associated with sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Pregnancy outcome following prescription for sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Considerations on the use of propranolol in complicated migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Migraine prophylactic drugs: proof of efficacy, utilization and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Successful treatment of persistent migraine aura with divalproex sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Pregnancy outcome following first trimester exposure to sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Letter: Propranolol in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Basilar artery migraine: a follow-up study of 82 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Case-control study of migraine and risk of ischaemic stroke in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Distribution and excretion of sumatriptan in human milk

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Cardiac risk factors and the use of triptans: a survey study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

Is there an increased risk of stroke associated with oral contraceptives?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970003-7

7 January 2021

10.1016/S0733-8619(05)70003-7

Identifiers

DOI

1 reference

1 August 2017

1 reference